🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessUnited Healthcare PA criteria for Wegovy — 12 month update Page 4

United Healthcare PA criteria for Wegovy — 12 month update

VanRx_Mike Sat, Feb 1, 2025 at 4:55 AM 45 replies 2,158 viewsPage 4 of 9
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Feb 1, 2025 at 10:35 AM#16

Just wanted to say — for anyone reading this United Healthcare PA thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Feb 1, 2025 at 4:35 PM
13 23PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 10 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Feb 1, 2025 at 10:52 AM#17

VanRx_Mike's experience with United Healthcare PA resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 50 lbs in 5 months.

One thing I would add that VanRx_Mike did not mention: the mental health improvements were just as significant.

5 16bbq_ray_KC, oliver_london, tane_welly and 2 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Feb 1, 2025 at 11:09 AM#18

Saving this for reference. Top-tier content.

47 5AttorneyGrant, DebRD_ATL, KristenIndy and 44 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Feb 1, 2025 at 11:26 AM#19

As a pharmacist, I want to add some clinical context to this discussion on United Healthcare PA criteria for Wegovy.

Building on what VanRx_Mike said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 1, 2025 at 1:26 PM
26 19Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 23 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Feb 1, 2025 at 11:43 AM#20

Subscribing to this thread. United Healthcare PA is exactly what I've been researching. 🙏

Last edited: Feb 1, 2025 at 5:43 PM
7 18mike_mealprep, NicoleRaleigh, james_edin and 4 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register